Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? (Q39737196)

14 September 2017

Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? (English)

1 reference

14 September 2017

0 references

4

1 reference

14 September 2017

Erin D Kennedy

1

1 reference

14 September 2017

Selina Schmocker

2

1 reference

14 September 2017

Charles Victor

3

1 reference

14 September 2017

John Kim

5

1 reference

14 September 2017

James Brierley

6

1 reference

14 September 2017

Robin S McLeod

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

10 January 2011

1 reference

14 September 2017

1 reference

14 September 2017

117

1 reference

14 September 2017

13

1 reference

14 September 2017

2853-2862

1 reference

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Neoadjuvant treatment of rectal carcinoma: assessment of health care services by physicians and lay persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

A decision aid to assist in adjuvant therapy choices for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

Preoperative staging of rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

The prognostic inhomogeneity in pT3 rectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

The TME Trial After a Median Follow-up of 6 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Are we overtreating rectal cancer: time for another trial?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Whose guidelines are they anyway?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

In the queue for coronary artery bypass grafting: patients' perceptions of risk and 'maximal acceptable waiting time'.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25842

7 January 2021

Identifiers

DOI

10.1002/CNCR.25842

1 reference

14 September 2017

1 reference